Aspartame is a very intense artificial sweetener, about 180 to 300 times sweeter than sugar, widely used in diet drinks and “sugar-free” foods. It has been studied for decades, with many agencies judging it safe within set daily limits, but some recent research and reviews continue to question possible long-term risks and as a result many people worry if it is ok to enjoy it in their favourite fizzy drinks or should they avoid it altogether.

What Aspartame Is and Where It’s Found

Chemically, aspartame is a dipeptide of aspartic acid and phenylalanine with a methyl ester. It provides 4 kcal per gram, but it is used in such tiny amounts that calorie contribution is considered negligible in real-world intake.

It is commonly found in diet soft drinks, powdered drink mixes, chewing gum, flavoured milk, desserts, “light” or diet foods, and some medicines. In German market data, it appeared in around 14% of 53,116 tested samples, particularly in powdered drink bases, flavoured milk drinks, chewing gum, and diet sodas, so needless to say, it is an ingredient you are highly likely to come across even in Ireland.

Acceptable Daily Intake and Typical Exposure

Regulatory agencies have set safe intake thresholds based on decades of toxicological and epidemiological evidence.

The U.S. Food and Drug Administration has set an acceptable daily intake (ADI) of 50 mg per kg of body weight per day, while the European Food Safety Authority has set this at 40 mg per kg per day. Current exposure data suggests that average and even high consumers remain below these levels, including in the US population.

How the Body Handles Aspartame

After ingestion, aspartame is completely broken down in the gut into phenylalanine (about 50%), aspartic acid (about 40%), and methanol (about 10%). These compounds are also naturally present in many everyday foods and are metabolised in normal physiological pathways.

A key exception however is individuals with phenylketonuria. People with Phenylketonuria cannot metabolise phenylalanine properly and must avoid aspartame completely. This is why products containing aspartame carry the warning that they contain a source of phenylalanine.

Cancer and Carcinogenicity Evidence

Large toxicology programmes in animals, including studies at very high doses of 4000 mg per kg per day or more, have not shown credible carcinogenic effects. Systematic reviews and regulatory assessments generally conclude there is no consistent evidence that aspartame causes cancer in humans, and overall certainty of harm is considered very low.

However, not all evidence is aligned.

A large French cohort study found higher total cancer risk, including breast and obesity-related cancers, in higher consumers of aspartame. The hazard ratios ranged approximately from 1.13 to 1.22, but the authors noted that residual confounding, reverse causality, and bias could not be excluded.

Network toxicology and docking studies have also suggested possible molecular interactions with cancer-related proteins, but these remain theoretical and require confirmation in vivo.

Some recent narrative reviews continue to describe chronic consumption as potentially “treacherous” or carcinogenic based mainly on animal or mechanistic data, and recommend caution with long-term high intake.

Neurocognitive and Neurological Effects

Experimental animal studies have shown oxidative stress, neuronal loss, and learning or memory impairment at a range of doses, sometimes at or below accepted daily intake levels.

A scoping review reports mood changes, depression-like and anxiety-like behaviour in animal models, and some human data suggesting possible behavioural or mood effects at high daily intake. It also suggests that people with pre-existing neurological or metabolic conditions may be more vulnerable.

Because of concerns relating to neurotoxicity and glutamate receptor activity, several reviews recommend extra caution in people with seizure disorders, neurological disease, or during pregnancy.

Metabolic Effects, Obesity, and Diabetes

A 2025 systematic review and meta-analysis of controlled human trials found little to no effect of aspartame on blood glucose or insulin compared with water or other low-calorie sweeteners, and significantly lower responses compared with sugar. Effects were observed both acutely and over several weeks to months.

Long-term animal research with non-nutritive sweeteners shows no consistent evidence of major weight gain or metabolic harm overall, although aspartame has in some cases been linked to reduced glucose tolerance under specific conditions.

Reviews on obesity suggest that while artificial sweeteners may reduce calorie intake, they could also influence gut microbiota, insulin signalling, and appetite regulation in ways that are still not fully understood.

Regulatory and Epidemiological Perspectives

Overall, the evidence can be summarised as follows.

The strongest evidence supports the conclusion that aspartame is safe at current typical intakes for the general population, excluding individuals with PKU. This is supported by large margins below the ADI, multiple regulatory reviews, and the absence of a convincing cancer signal in human data.

Moderate evidence suggests that high or chronic intake may pose risks in certain contexts, including neurocognitive effects, oxidative stress, or possible cancer signals. However, these findings are inconsistent and often based on animal or low-quality observational data.

The World Health Organization expert committee (JECFA) reaffirmed safety at current intakes and concluded that human cancer evidence is not convincing, with overall certainty rated very low.

Other narrative reviews highlight ongoing controversy, possible neurodegenerative or systemic effects, and argue that chronic regular use may still require further investigation and better labelling.

Who Should Be Most Cautious

People with phenylketonuria must avoid aspartame entirely due to inability to metabolise phenylalanine.

Pregnant women, children, and people with neurological conditions or seizure disorders are often advised in some reviews to limit or avoid aspartame as a precaution, even though regulatory agencies still consider it safe within ADI levels.

Individuals consuming large amounts of diet products daily may approach the ADI, so clearer labelling of exact content is often recommended to help manage intake.

Why Some People Think It Is Unsafe

Aspartame remains one of the most studied food additives, yet findings are mixed, which contributes to public concern.

Neurocognitive concerns include headaches, mood changes, anxiety, depression, insomnia, and memory issues, particularly at higher intake levels or in animal studies. Proposed mechanisms include increased brain phenylalanine and aspartate levels, neurotransmitter disruption, oxidative stress, and neuronal effects.

Cancer concerns are driven by several factors, including a French cohort showing small risk increases, animal tumour findings from the Ramazzini Institute, and mechanistic studies suggesting possible carcinogenic pathways. The IARC classification of aspartame as “possibly carcinogenic” also contributed to public concern, although this reflects limited evidence rather than confirmed harm.

Other theoretical risks discussed in reviews include neurodegeneration, seizures, allergies, reproductive issues, kidney effects, and systemic oxidative stress, mostly based on animal or high-dose studies.

At the same time, regulatory reviews and many epidemiological studies conclude no clear carcinogenicity or major harm at typical intake levels, creating a split in interpretation that fuels ongoing debate.

What Is the Reality of Its Safety

Across regulatory bodies and large-scale reviews, aspartame is considered safe for most people at typical intake levels. Population exposure is generally well below ADI limits, and long-term toxicological and epidemiological studies have not identified consistent harm in humans.

At the same time, there are credible signals from animal and mechanistic studies, along with some observational findings, that suggest possible neurocognitive effects, oxidative stress, and small cancer associations at higher intake levels. These findings are not consistent and are often low certainty.

The most accurate interpretation is that aspartame is safe within current guidelines for the general population, but uncertainty remains around long-term high intake and certain vulnerable groups.

How Safe Is It to Drink Fizzy Drinks With Aspartame and How Much Would Be Unsafe

For most healthy people, drinking fizzy drinks with aspartame is considered safe at usual amounts.

Regulatory acceptable daily intakes are 40 mg per kg body weight per day in Europe and 50 mg per kg in the US. For a 70 kg adult, this roughly translates to around 9 to 16 cans of diet soda per day depending on brand and formulation before reaching the upper limit.

Population studies show that even high consumers generally remain below these thresholds.

Concerns typically arise at very high chronic intakes, where animal studies have shown oxidative stress and behavioural changes, although these are not directly comparable to normal human consumption levels.

Certain groups should be more cautious, including people with PKU, pregnant women, young children, and those with neurological conditions.

If You Are Generally Healthy and Still Concerned

If you are generally healthy and still concerned, it is reasonable to keep intake well below the ADI, for example occasional or a few diet drinks per day rather than high daily consumption.

It may also be helpful to vary sweeteners and include unsweetened options such as water, tea, or coffee to reduce cumulative exposure.

If you notice reproducible symptoms such as headaches, mood changes, or gastrointestinal discomfort that consistently occur after consuming aspartame, several reviews suggest trial reduction or avoidance to see if symptoms improve.

Take Home Message

Aspartame is one of the most extensively researched food additives in the world. The majority of evidence supports its safety at current intake levels for the general population, with the clear exception of people with phenylketonuria.

Concerns remain due to mixed findings in animal studies, observational research, and mechanistic theories, but these have not translated into consistent evidence of harm in humans at typical dietary exposures.

For most people, the key issue is not avoidance but moderation and overall dietary pattern. High intake is very different from occasional consumption, and context matters more than single ingredients.

---

References

Magnuson BA, Burdock GA, Doull J, et al. Aspartame: A safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Critical Reviews in Toxicology. 2007;37(8):629-727.

Makar Abdel Messih N. The safety of aspartame. JAMA. 2015 Mar 30.

Wojcieszonek A, Szpyt J, Pajor K, Hawryłkowicz V. Can aspartame-sweetened products safely help with weight loss? Journal of Education, Health and Sport. 2020 Sep 15.

Biernikiewicz M, Biernikiewicz J, Wilewska A, et al. Aspartame in the diet: A contribution to the debate on safety and health impact. Journal of Education, Health and Sport. 2025 Feb 12.

Zhang Y. Aspartame: A review of functional properties and physiology impacts of aspartame. Theoretical and Natural Science. 2024 Jul 26.

Choudhary A, Pretorius E. Revisiting the safety of aspartame. Nutrition Reviews. 2017 Sep;75(9):718-730.

Czarnecka K, Pilarz A, Rogut A, et al. Aspartame—True or False? Narrative review of safety analysis of general use in products. Nutrients. 2021 Jun;13(6):1957.

Solmaz F, Dıraman E, Sezgin B. Current approaches to the use of artificial sweetener aspartame. 2021 Mar 30.

Burh A, Batra S, Sharma S. Emerging facts on chronic consumption of aspartame as food additive. Current Nutrition & Food Science. 2021 Aug 12.

Ali W, Mohammed SA, Abdullah EM, ElDeen EMS. Aspartame: Basic information for toxicologists. Sohag Medical Journal. 2019 Apr 1.

Shaher SAA, Mihailescu D, Amuzescu B. Aspartame safety as a food sweetener and related health hazards. Nutrients. 2023 Aug;15(15):3410.

Goodman J, Boon D, Jack MM. Perspectives on recent reviews of aspartame cancer epidemiology. Global Epidemiology. 2023 Aug;5:100109.

El Doueihy N, Ghaleb J, Kfoury K, et al. Aspartame and human health: A mini-review of carcinogenic and systemic effects. Journal of Xenobiotics. 2025 Jul 7.

Riess L, Huynh BQ, Nachman KE. Aspartame exposures in US population studies using NHANES data. Journal of Exposure Science & Environmental Epidemiology. 2024 May 9.

Schorb S, Gleiss K, Wedekind R, et al. Assessment of aspartame occurrence in foods and beverages on the German market. Foods. 2023 May 26.

Knezovic Z, Jurcevic Zidar B, Pribisalić A, et al. Artificial sweeteners in food products intake assessment. Nutrients. 2025 Mar 22.

Trawiński J, Skibiński R. Stability of aspartame in soft drinks and toxicity evaluation. Food Research International. 2023 Aug;170:113996.

Jones SK, McCarthy DM, Vied C, et al. Transgenerational transmission of aspartame-induced anxiety. PNAS. 2022.

Fowler SP, et al. Early-life exposure to diet soda and autism outcomes. Nutrients. 2023.